TruAlt Bioenergy Limited (BOM:544545)
India · Delayed Price · Currency is INR 446.10
-17.50 (-3.77%)
At close: Aug 21, 2026
TruAlt Bioenergy Revenue
TruAlt Bioenergy had revenue of 6.27B INR in the quarter ending June 30, 2026, with 106.29% growth. This brings the company's revenue in the last twelve months to 20.50B, up 1.80% year-over-year. In the fiscal year ending March 31, 2026, TruAlt Bioenergy had annual revenue of 17.28B, down -9.45%.
Revenue (ttm)
20.50B
Revenue Growth
+1.80%
P/S Ratio
1.87
Revenue / Employee
15.97M
Employees
1,284
Market Cap
38.26B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 17.28B | -1.80B | -9.45% |
| Mar 31, 2025 | 19.08B | 6.84B | 55.94% |
| Mar 31, 2024 | 12.23B | 4.61B | 60.47% |
| Mar 31, 2023 | 7.62B | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Polyplex Corporation | 76.01B |
| Filatex India | 42.56B |
| TVS Srichakra | 38.92B |
| Pondy Oxides And Chemicals | 32.90B |
| Aarti Drugs | 26.78B |
| Unichem Laboratories | 23.08B |
| Pitti Engineering | 19.85B |
| TCPL Packaging | 18.79B |